Results 201 to 210 of about 194,359 (349)

Use of Granulocyte-Colony Stimulating Factor for Beta-Lactam Induced Neutropenia in Children With Bacterial Meningitis. [PDF]

J Pediatr Pharmacol Ther
Yen CY, Kaplan SL, Palazzi DL, Stimes G.
europepmc   +1 more source

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre, Corinna Maier, Jiuhong Zha, Benjamin Engelhardt, Johannes E. Wolff, Sven Mensing   +5 more
wiley   +1 more source

Sarcopenia attenuates the efficacy of PEGylated granulocyte colony-stimulating factor in preventing febrile neutropenia. [PDF]

Support Care Cancer
Go SI, Jeong EJ, Lee WJ, Park S, Park MJ, Lee GW.   +5 more
europepmc   +1 more source

Effect of remobinant granulocyte-macrophage colony stimulating factor (GM-CSF) on leukopenia in AIDS [PDF]

, 1991
Bogner, Johannes R., Chatterjee, M., Ganser, A., Goebel, Frank-Detlef, Helm, E. B., Hoelzer, D., Ottmann, O. G., Seipelt, G.   +7 more
core  

Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy

, 2007
信宏 兼村
openalex   +1 more source

Phase I / II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancer

, 1999
G. Thomas Budd, Joshua O. Atiba, Richard T. Silver, G. Palmer, Sharon Armstrong, Kristen J. Otto, Cary A. Presant   +6 more
openalex   +2 more sources

Mesenchymal stromal cell therapy for rheumatoid arthritis: Long‐term efficacy, safety, and mechanistic insights

Rheumatology &Autoimmunity, EarlyView.
Graphical abstract summarizing the multifactorial pathogenesis of rheumatoid arthritis (RA) and the therapeutic potential of mesenchymal stromal cell (MSC) therapy. MSCs provide promising benefits through their immunomodulatory properties, low immunogenicity, ability to promote tissue repair, and multi‐lineage differentiation, presenting a potential ...
Yingjia Chen, Ruiyu Gao, Xing Guo, Genhong Yao, Xiaojun Tang, Yile E. Liu, Lingyun Sun   +6 more
wiley   +1 more source

Granulocyte colony-stimulating factor-associated aortitis in a man with advanced prostate cancer. [PDF]

IJU Case Rep
Ikadai R, Kitano G, Kato M, Kojima T.
europepmc   +1 more source

Inhaled GM-CSF in neonatal mice provides durable protection against bacterial pneumonia [PDF]

, 2019
Morley, S. Celeste, Ramani, Rashmi, Szasz, Taylor P, Todd, Elizabeth M   +3 more
core   +2 more sources

Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances cumulus cell expansion in bovine oocytes [PDF]

, 2013
Óscar A. Peralta, D. Bücher, A. Fernández, Marco Berland, Pablo Strobel, Alfredo Ramírez‐Reveco, Marcelo Ratto, Ilona I. Concha   +7 more
openalex   +1 more source